Can DCN Dx integrate biospecimen procurement with a broader clinical study?

Yes. Because DCN Dx is both a biospecimen services company and a CRO and CDMO, we can integrate specimen procurement directly into your clinical validation study, assay development program, or regulatory submission. One contract, one quality system, one team aligned to your milestones. This eliminates the handoff challenges encountered when specimen providers, CROs, and regulatory teams operate independently.